Home Business Indian pharma firm pulls heart drug from US amid cancer risk probes

Indian pharma firm pulls heart drug from US amid cancer risk probes

By
Lucky Jain
-
446
0
(G.N.S) Dt. 11 New Delhi A unit of India’s Hetero Drugs is recalling some batches of the blood pressure and heart medicine valsartan in the United States, a notice on the US regulator’s website said, amid a wider probe into cancer risks associated with the drug. The United States-based unit

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   
New User Registration
*Required field

RELATED ARTICLESMORE FROM AUTHOR